Baas, Lieke http://orcid.org/0000-0001-6032-2712
Meijer, Karina
Bredenoord, Annelien L.
van der Graaf, Rieke
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWA.1160.18.038)
Article History
Accepted: 5 August 2024
First Online: 22 August 2024
Declarations
:
: Dr. Meijer reports speaker fees from Alexion, Bayer and CSL Behring, participation in trial steering committees for Bayer and Astra Zeneca, consulting fees from Uniqure and Therini, participation in data monitoring and endpoint adjudication committee for Octapharma. All other authors have no competing interests to disclose.